Panbela Therapeutics Inc (PBLA) Q3 2024 Earnings Call Highlights: Strategic Loan and Clinical ... [Yahoo! Finance]
PANBELA THERAPEUTICS INC (PBLA)
Company Research
Source: Yahoo! Finance
Panbela Therapeutics Inc ( PBLA ) secured a $12 million strategic loan commitment from Napp Capital, which represents both financial backing and a potential clinical alliance. The company's lead program, the phase three Aspire global clinical trial, is progressing well with a faster than expected enrollment rate. Panbela Therapeutics Inc ( PBLA ) has observed a notably lower event rate in their Aspire trial, potentially indicating better patient outcomes. The company is advancing multiple clinical programs, including a phase two trial in castration-resistant metastatic prostate cancer and a type one diabetes trial. Panbela Therapeutics Inc ( PBLA ) continues to expand its clinical pipeline with promising preclinical data and collaborations with prestigious institutions like MD Anderson Cancer Center. Panbela Therapeutics Inc ( PBLA ) reported a net loss of $7.2 million for the quarter, indicating ongoing financial challenges. The company's total cash as of September 30th,
Show less
Read more
Impact Snapshot
Event Time:
PBLA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBLA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBLA alerts
High impacting PANBELA THERAPEUTICS INC news events
Weekly update
A roundup of the hottest topics
PBLA
News
- Panbela Provides Business Update and Reports Q3 2024 Financial ResultsGlobeNewswire
- Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024GlobeNewswire
- First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer CenterGlobeNewswire
PBLA
Earnings
- 8/13/24 - Beat
PBLA
Sec Filings
- 11/19/24 - Form 4
- 11/18/24 - Form 424B3
- 11/18/24 - Form 424B3
- PBLA's page on the SEC website